Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for GABAPENTIN

Ingredient

GABAPENTIN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
MINT-GABAPENTIN	400MG	CAPSULE	Actual shortage	2026-02-09	2026-02-09	277609
MYLAN-GABAPENTIN	800MG	TABLET	Resolved	2017-04-13	2017-08-24	7020
MYLAN-GABAPENTIN	600MG	TABLET	Resolved	2017-04-13	2017-08-24	7017
MYLAN-GABAPENTIN	100MG	CAPSULE	Resolved	2017-04-04	2017-08-24	5301
MYLAN-GABAPENTIN	300MG	CAPSULE	Resolved	2017-04-04	2017-08-24	5322
MYLAN-GABAPENTIN	300MG	CAPSULE	Resolved	2017-04-13	2017-08-24	7014
MYLAN-GABAPENTIN	400MG	CAPSULE	Resolved	2017-04-07	2017-12-02	5976
NEURONTIN	800MG	TABLET	Resolved	2022-09-01	2022-10-05	168396
NEURONTIN	400MG	CAPSULE	Actual shortage	2026-01-13	2026-02-10	275980
NEURONTIN	100MG	CAPSULE	Resolved	2023-06-27	2023-07-25	196704

Previous
1
…
11
12
13
14
15
…
20
Next

Showing 121 to 130 of 199

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
RAN-GABAPENTIN	400MG	CAPSULE	Discontinued	2019-03-29	2019-03-29	80051

Showing 11 to 11 of 11